All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit
- 31 July 2008
- journal article
- Published by Elsevier BV in Journal of Pediatric Surgery
- Vol. 43 (7), 1284-1294
- https://doi.org/10.1016/j.jpedsurg.2008.01.007
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Long-term outcomes in patients with stage IV neuroblastomaJournal of Pediatric Surgery, 2006
- ‘Cross-talk’ between Schwannian stroma and neuroblasts promotes neuroblastoma tumor differentiation and inhibits angiogenesisCancer Letters, 2005
- Signaling pathways in retinoid chemoprevention and treatment of cancerMutation Research, 2004
- The Brn-3b Transcription Factor Regulates the Growth, Behavior, and Invasiveness of Human Neuroblastoma Cells in Vitro and in VivoJournal of Biological Chemistry, 2004
- Retinoic acid‐induced neuritogenesis of human neuroblastoma SH‐SY5Y cells is ERK independent and PKC dependentJournal of Neuroscience Research, 2003
- Cisplatin-induced cytotoxicity is blocked by brain-derived neurotrophic factor activation of TrkB signal transduction path in neuroblastomaCancer Letters, 2003
- Real Time RT-PCR Shows Correlation between Retinoid-Induced Apoptosis and NGF-R mRNA LevelsBiochemical and Biophysical Research Communications, 2001
- Regulation of NGF responsiveness in human neuroblastomaOncogene, 1998
- p27Kip1: a key mediator of retinoic acid induced growth arrest in the SMS–KCNR human neuroblastoma cell lineOncogene, 1998
- Association between High Levels of Expression of the TRK Gene and Favorable Outcome in Human NeuroblastomaNew England Journal of Medicine, 1993